RecruitingNot ApplicableNCT05670132

Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)

Impact of a Neuro-cardiac Rehabilitation Program on the Quality of Life of Children, Adolescents, and Young Adults With Congenital Heart Disease: the Multicentre Randomized Controlled QUALINEUROREHAB Trial


Sponsor

University Hospital, Bordeaux

Enrollment

192 participants

Start Date

Jun 3, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Remarkable progress in paediatric cardiology and surgery have led to the substantial increase of congenital heart disease (CHD) survivors. Long-term outcomes in rare and complex CHD have become a critical priority as three major sources of morbidity have been identified in this population: neurodevelopmental sequelae, mental health issues and reduced exercise capacity. These challenges adversely affect their quality of life and constitute a major public health issue. We seek to evaluate the efficacy of the first integrative and holistic program in Neuro-Cardiac Health associating physical and psychological rehabilitation for children with rare CHD compared to the standard of care. Children randomly assigned to the intervention will undergo a 12-week neuro-cardiac intervention including home-based adaptive physical exercise, telehealth parent and child psycho-education and child computerized cognitive training, as well in-person individual sessions of intervention reinforcement. Parents will be actively involved and will receive personalized feedback and educational resources. Children assigned to the control group will receive the standard of care in congenital cardiology. Post-intervention effects will be measured after 12-months on several outcomes including health-related quality of life (HRQoL), trained and untrained cognitive skills, mental health outcomes and cardiovascular/physical variables.


Eligibility

Min Age: 8 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Neurocardiac rehabilitation program and Standard of care for people with congenital heart disease. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 8 Years to 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNeurocardiac rehabilitation program

Patients receiving a neurocardiac rehabilitation program for 12 weeks.

OTHERStandard of care

No intervention during the neurocardiac rehabilitation program


Locations(6)

Saint-Luc University Hospital

Brussels, Belgium

Hôpital Necker-Enfants malades (AP-HP)

Paris, France, France

University Hospital of Montpellier - Arnaud de Villeneuve Hospital

Montpellier, France

Saint-Pierre Institute

Palavas-les-Flots, France

University Hospital of Bordeaux - Haut-Levêque Hospital

Pessac, France

Deutsches Herzzentrum München

München, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05670132


Related Trials